Last Price$23.01.3%
Market Cap$11.6B
LTM Research & Development Expenses (R&D)
$15.1M
YoY Growth
-3.8%
3Y CAGR
N/A
5Y CAGR
+31.1%
Stock quality & Intrinsic value
7/10
178.0% undervalued
Rentokil Initial plc Research & Development Expenses (R&D)
Annual
Quarterly
LTM
Crunching data... Almost there!
| Dec'04 | Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Research & Development Expenses (R&D) | $5,315.7K | $5,460.6K | $5,159.0K | $3,402.9K | $3,149.8K | $2,662.5K | $2,937.2K | $3,207.0K | $0.0 | $2,817.0K | $2,635.8K | $0.0 | $0.0 | $0.0 | $0.0 | $0.0 | $0.0 | $6,876.3K | $6,185.7K | $0.0 |
Overvalued or undervalued?
Check the intrinsic value for RTO
and see if it's the right time to invest.
Rentokil Initial plc (RTO) Research & Development Expenses (R&D) comparison analysis
General
LTM Research & Development Expenses (R&D)
Growth
Company name
YoY growth
3Y CAGR
5Y CAGR
Rentokil Initial plcRTO
$15.1M
(3.8%)
N/A
38.0%
Median Peer Set
$0.0
0.0%
0.0%
0.0%
Cintas CorporationCTAS
$26.6M
8.6%
6.1%
4.3%
First Advantage CorporationFA
$25.4M
(48.5%)
(17.7%)
N/A
AramarkARMK
$0.0
N/A
N/A
N/A
CBIZ, Inc.CBZ
$0.0
N/A
N/A
N/A
ABM Industries IncorporatedABM
$0.0
N/A
N/A
N/A
Global Payments Inc.GPN
$0.0
N/A
N/A
(100.0%)
UniFirst CorporationUNF
$0.0
N/A
N/A
N/A
Maximus, Inc.MMS
$0.0
N/A
N/A
N/A
RB Global, Inc.RBA
$0.0
N/A
N/A
N/A
Thomson Reuters CorporationTRI
$0.0
(100.0%)
N/A
N/A
RTO key stats
USD
GBP
Millions
Billions
Annual
Quarterly
Trailing
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
| Dec'04 | Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
% growth | 3,998.5 0.0% | 3,431.4 (14.2%) | 3,396.1 (1.0%) | 4,410.5 29.9% | 4,465.1 1.2% | 3,963.7 (11.2%) | 3,859.3 (2.6%) | 4,079.7 5.7% | 4,035.8 (1.1%) | 3,642.0 (9.8%) | 2,867.7 (21.3%) | 2,688.3 (6.3%) | 2,939.8 9.4% | 3,107.7 5.7% | 3,299.9 6.2% | 3,416.0 3.5% | 3,581.1 4.8% | 4,062.4 13.4% | 4,594.8 13.1% | 6,683.7 45.5% |
| Cost of Goods Sold (COGS) | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 433.8 | 490.1 | 474.1 | 510.0 | 611.8 | 686.3 | 2,679.3 | 2,742.7 | 3,079.3 | 3,386.1 | 1,152.7 |
% margin | 3,998.5 100.0% | 3,431.4 100.0% | 3,396.1 100.0% | 4,410.5 100.0% | 4,465.1 100.0% | 3,963.7 100.0% | 3,859.3 100.0% | 4,079.7 100.0% | 4,035.8 100.0% | 3,208.2 88.1% | 2,377.7 82.9% | 2,214.2 82.4% | 2,429.9 82.7% | 2,495.9 80.3% | 2,613.5 79.2% | 736.8 21.6% | 838.3 23.4% | 983.0 24.2% | 1,208.7 26.3% | 5,531.0 82.8% |
| Operating Expenses | 3,464.0 | 2,899.8 | 3,035.1 | 4,017.2 | 4,281.1 | 3,761.8 | 3,601.5 | 3,859.4 | 3,804.7 | 3,373.9 | 2,036.8 | 1,911.9 | 2,094.4 | 1,522.7 | 2,705.2 | 411.7 | 451.9 | 479.4 | 592.6 | 4,753.8 |
| Research & Development Expenses (R&D) | 5.3 | 5.5 | 5.2 | 3.4 | 3.1 | 2.7 | 2.9 | 3.2 | 0.0 | 2.8 | 2.6 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 6.9 | 6.2 | 0.0 |
| Selling, General & Administrative Expenses (SG&A) | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 5.2 | 1,541.4 | 1,475.9 | 1,623.9 | 1,712.9 | 1,820.6 | 411.7 | 451.9 | 479.4 | 592.6 | 3,568.8 |
% margin | 565.5 14.1% | 491.6 14.3% | 395.2 11.6% | 424.2 9.6% | 152.1 3.4% | 186.8 4.7% | 95.1 2.5% | (16.4) (0.4%) | 231.1 5.7% | 268.1 7.4% | 355.5 12.4% | 331.3 12.3% | 348.9 11.9% | 406.4 13.1% | 377.9 11.5% | 325.1 9.5% | 386.4 10.8% | 503.6 12.4% | 616.1 13.4% | 777.2 11.6% |
| Interest Income | 113.5 | 108.5 | 25.4 | 34.0 | 69.5 | 18.3 | 6.5 | 9.5 | 114.8 | 24.6 | 72.0 | 59.3 | 52.7 | 53.8 | 60.6 | 5.2 | 3.0 | 1.1 | 6.2 | 31.1 |
| Interest Expense | 211.7 | 211.7 | 130.4 | 174.1 | 166.9 | 23.0 | 12.2 | 8.8 | 173.9 | 110.6 | 90.8 | 58.5 | 52.2 | 44.8 | 47.5 | 48.8 | 51.7 | 45.8 | 91.5 | 235.0 |
| Pre-tax Income | 470.5 | 395.7 | 304.7 | 284.2 | 42.2 | 101.8 | 22.4 | (81.0) | 131.1 | 191.9 | 268.9 | 243.0 | 282.7 | 919.3 | (152.3) | 412.7 | 284.4 | 436.0 | 355.1 | 613.0 |
% effective tax rate | 127.9 27.2% | 108.1 27.3% | 61.4 20.1% | 60.7 21.3% | 11.9 28.1% | 25.2 24.8% | 53.8 240.0% | 26.6 (32.9%) | 46.0 35.1% | 49.1 25.6% | 61.1 22.7% | 53.0 21.8% | 55.2 19.5% | 39.4 4.3% | 21.1 (13.8%) | 69.8 16.9% | 55.8 19.6% | 85.1 19.5% | 79.2 22.3% | 139.3 22.7% |
% margin | 349.0 8.7% | 585.2 17.1% | 451.6 13.3% | 1,313.7 29.8% | 34.8 0.8% | 74.6 1.9% | (36.2) (0.9%) | (111.8) (2.7%) | 81.5 2.0% | 58.7 1.6% | 207.7 7.2% | 190.0 7.1% | 227.1 7.7% | 879.6 28.3% | (131.2) (4.0%) | 362.3 10.6% | 238.8 6.7% | 361.7 8.9% | 287.0 6.2% | 473.8 7.1% |
| EPS | 0.97 | 1.62 | 1.25 | 3.64 | 0.10 | 0.20 | (0.02) | (0.06) | 0.22 | 0.16 | 0.11 | 0.10 | 0.12 | 0.48 | (0.07) | 0.19 | 0.13 | 0.19 | 0.15 | 0.19 |
| Diluted EPS | 0.97 | 1.62 | 1.25 | 3.64 | 0.10 | 0.20 | (0.02) | (0.06) | 0.22 | 0.16 | 0.11 | 0.10 | 0.12 | 0.48 | (0.07) | 0.19 | 0.13 | 0.19 | 0.15 | 0.19 |
% margin | 934.5 23.4% | 839.8 24.5% | 736.3 21.7% | 845.5 19.2% | 657.4 14.7% | 619.1 15.6% | 667.8 17.3% | 737.8 18.1% | 622.6 15.4% | 649.0 17.8% | 676.1 23.6% | 624.6 23.2% | 663.1 22.6% | 648.2 20.9% | 199.9 6.1% | 741.1 21.7% | 745.9 20.8% | 902.2 22.2% | 948.9 20.7% | 1,438.7 21.5% |
Discover more Stock Ideas
Undervalued stocks right now
Discover the top 20 best undervalued stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.
3M Return 32.1%
S&P Outperformance 19.1%
Next 3M Predicted Return 20.3%
Undervalued growth stocks
Discover the top 20 best undervalued large-cap growth stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.
3M Return 35.3%
S&P Outperformance 22.3%
Next 3M Predicted Return 26.8%
Undervalued dividend stocks
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Mar 2025.
3M Return 28.4%
S&P Outperformance 15.4%
Next 3M Predicted Return 16.9%
FAQ
1) What is Rentokil Initial plc's Research & Development Expenses (R&D)?
As of today, Rentokil Initial plc's last 12-month Research & Development Expenses (R&D) is $15.1M, based on the financial report for Jun 30, 2024 (Q2’2024).
2) What is Rentokil Initial plc's Research & Development Expenses (R&D) growth rate?
Over the last year, Rentokil Initial plc's Research & Development Expenses (R&D) growth was (3.8%). The average annual Research & Development Expenses (R&D) growth rates for Rentokil Initial plc have been N/A over the past three years, 31.1% over the past five years.